Qingshu Zeng

Desialylation is a mechanism of Fc-independent platelet clearance and a therapeutic target in immune thrombocytopenia

June Li, Dianne E. van der Wal, Guangheng Zhu et al. · Nature Communications · 2015 · 359 citations · Full text

Relative efficacy of steroid therapy in immune thrombocytopenia mediated by anti‐platelet GPIIbIIIa versus GPIbα antibodies

Qingshu Zeng, Lingyan Zhu, Lili Tao et al. · American Journal of Hematology · 2011 · 101 citations · Full text

Immunohematology, Immunodeficiencies, Immunology +23

High‐dose dexamethasone plus recombinant human thrombopoietin vs high‐dose dexamethasone alone as frontline treatment for newly diagnosed adult primary immune thrombocytopenia: A prospective, multicenter, randomized trial

Yafei Yu, Miaomiao Wang, Yu Hou et al. · American Journal of Hematology · 2020 · 58 citations · Full text

Anthracycline dose optimisation in patients with diffuse large B-cell lymphoma: a multicentre, phase 3, randomised, controlled trial

Pengpeng Xu, Di Fu, Jianyong Li et al. · The Lancet Haematology · 2019 · 46 citations

Hematological Malignancy, Lymphoid Neoplasia, Anthracycline Dose Optimisation +6

Efficacy and safety of sovleplenib (HMPL-523) in adult patients with chronic primary immune thrombocytopenia in China (ESLIM-01): a randomised, double-blind, placebo-controlled, phase 3 study

Yu Hu, Xiaofan Liu, Hu Zhou et al. · The Lancet Haematology · 2024 · 24 citations

Thrombopoiesis, Thrombosis, Venous Thrombosis +10